Acute effects of interferon on estrogen receptor function do not involve the extracellular signal-regulated kinases p42(mapk) and p44(mapk)

Journal of Interferon and Cytokine Research

Volumn 20, Issue 2, 2000, Pages 225-233

  Flint, A P F ^a   Abayasekara, D R E ^b   Wheeler Jones, C P D ^b   Riley, P R ^a,c   Kaluz, S ^a,d   Kaluzova, M ^a,d   Sheldrick, E L R ^a   Fisher, P A ^a,e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF VIROLOGY   (Slovakia)

^e LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CATTLE; ENZYME PHOSPHORYLATION; IMMUNOREGULATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; GENE EXPRESSION; GENES, REPORTER; INDOLES; INTERFERON TYPE I, RECOMBINANT; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, ESTROGEN;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0033995241     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312649     Document Type: Article

References (65)

1. 1. Van Biesen, T., Luttrell, L.M., Hawes, B.E., and Lefkowitz, R.J. (1996). Mitogenic signalling via G protein coupled receptors. Endocr. Rev. 17, 698-714.
2. 2. Lange-Carter, C.A., Pleiman, C.M., Gardner, A.M., Blumer, K.J., and Johnson, G.L. (1993). A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260, 315-319.
3. 3. Gutkind, J.S. (1998). The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 1839-1842.
4. 4. Conway, A.-M., Rakhit, S., Pyne, S., and Pyne, N.J. (1999). Platelet-derived growth factor stimulation of p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Biochem. J. 337, 171-177.
5. 5. Schindler, C., and Darnell, J.E., Jr. (1995). Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64, 621-651.
6. 6. Winston, L.A., and Hunter, T. (1995). Jak2, Ras and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270, 30837-30840.
7. 2α stimulates tyrosine phosphorylation and mitogen-activated protein kinase in osteoblastic MC3T3-E1 cells via protein kinase C activation. Endocrinology 138, 1821-1828.
8. 8. Blenis, J. (1993). Signal transduction via MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90, 5889-5892.
9. 9. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
10. 10. Ogawa, S., Inoue, S., Watanabe, T., Hiroi, H., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. (1998). The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun. 243, 122-126.
11. 11. Kaluz, S., Kaluzova, M., and Flint, A.P.F. (1997). Sequence variability in the A/B region of the estrogen receptor. Anim. Biotechnol. 8, 221-226.
12. 12. Gonzalez, F.A., Raden, D.L., and Davis. R.J. (1991). Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J. Biol. Chem. 266, 22159-22163.
13. 13. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., and Chambon, P. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59, 477-487.
14. 14. Le Goff, P., Montano, M.M., Schodin, D.J., and Katzenellenbogen, B.S. (1994). Phosphorylation of the human estrogen receptor. J. Biol. Chem. 269, 4458-4466.
15. 15. Bunone, G., Briand, P.-A., Miksicek, R.J., and Picard, D. (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183.
16. 16. Ignar-Trowbridge, D.M., Pimentel, M., Parker, M.G., McLachlan, J.A., and Korach, K.S. (1996). Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137, 1735-1744.
17. 17. Pouillart, T., Palangie, T., Jouvet, M., Garciagiralt, E., Fridman, W.H., Magdelenat, H., Falcoff, E., and Billiau, A. (1982). Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur. J. Cancer Clin. Oncol. 18, 929-935.
18. 18. Sica, G., Natoli, V., Stella, C., and Del Bianco, S. (1987). Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Cancer 60, 2419-2423.
19. 19. Vanden Berg, H.W., Leahey, W.J., Lynch, M., Clarke, R., and Nelson, J. (1987). Recombinant human interferon alpha increases estrogen receptor expression in human breastcancer cells (ZR-75-1) and sensitizes them to the antiproliferative effects of tamoxifen. Br. J. Cancer 55, 255-257.
20. 20. De Cicco, F., Sica, G., Benedetto, M.T., Ciabattoni, G., Rossiello, F., Nicosia, A., Lupi, G., Iacopino, F., Mancuso, S., and Dell'acqua, S. (1988). In vitro effects of β-interferon on steroid receptors and prostaglandin output in human endometrial adenocarcinoma. J. Steroid Biochem. 30, 359-362.
21. 21. Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
22. 22. David, M., Petriocoin, E., III, Benjamin, C., Pine, R., Weber, M.J., and Larner, A.C. (1995). Requirement for MAP kinase (ERK2) activity in interferon α-and interferon β-stimulated gene expression through STAT proteins. Science 269, 1721-1723.
23. 23. Stancato, L.F., Sakatsume, M., David, M., Dent, P., Dong, F., Petricoin, E.F., Krolewski, J.J., Silvennoinen, O., Saharinen, P., Pierce, J., Marshall, C.J., Sturgill, T., Finbloom, D.S., and Larner, A.C. (1997). Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a Jak1-dependent pathway. Mol. Cell. Biol. 17, 3833-3840.
24. 24. Pfeffer, L.M., Eisenkraft, B.L., Reich, N.C., Improta, T., Baxter, G., Daniel-Issakani, S., and Strulovici, B. (1991). Transmembrane signaling by interferon α involves diacylglycerol production and activation of the s isoform of protein kinase C in Daudi cells. Proc. Natl. Acad. Sci. USA 88, 7988-7992.
25. 3. J. Biol. Chem. 269, 32358-32367.
26. 26. Wen, Z., Zhong, Z., and Darnel, J.E., Jr. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
27. 27. Zhang, X., Blenis, J., Li, H.-C, Schindler, C., And Chenkiang, S. (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994.
28. 28. Pfeffer, L.M., Mullersman, J.E., Pfeffer, S.R., Murti, A., Shi, W., and Yang, C.H. (1997). STAT3 as an adapter to couple phosphatidyl 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276, 1418-1420.
29. 29. Bazer, F.W., and Johnson, H.M. (1991). Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents. Am. J. Reprod. Immunol. 26, 19-22.
30. 30. Mosselman, S., Polman, J., and Dijkema, R. (1996). ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53.
31. 31. Kuiper, G.G.J.M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., and Gustafsson, J.-Å. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870.
32. 32. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
33. 33. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
34. mapk in human umbilical vein endothelial cells by interleukin-1 α and tumor necrosis factor-α. Am. J. Physiol. 274, C789-C798.
35. 2α activates protein kinase C in human ovarian cells. Mol. Cell. Endocrinol. 91, 51-57.
36. 36. Persaud, S.J., Jones, P.M., Sugden, D., and Howell, S.L. (1989). Translocation of protein kinase-C in rat islets of Langer-hans - effects of a phorbol ester, carbachol and glucose. FEBS Lett. 245, 80-84.
37. 37. Miller, M.M., Simboli-Campbell, M., Zhu, X., Williamson, D.G., and Franks, D.J. (1994). Modulation of a renal estrogen receptor by protein kinase C. Receptors Channels 2, 33-40.
38. 38. Flint, A.P.F., Lamming, G.E., Stewart, H.J., and Abayasekara, D.R.E. (1994). The role of the endometrial oxytocin receptor in determining the length of the sterile oestrous cycle and ensuring maintenance of luteal function in early pregnancy in ruminants. Philos. Trans. Ry. Soc. Lond. [Biol.] 344, 291-304.
39. 39. Denton, R.R., Koszewski, N.J., and Notides, A.C. (1992). Estrogen receptor phosphorylation. J. Biol. Chem. 267, 7263-7268.
40. 40. Cho, H., and Katzenellenbogen, B.S. (1993). Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7, 441-452.
41. 41. Cook, S.J., Rubinfeld, B., Albert, I., and McCormick, F. (1993). RapV12 antagonizes ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts. EMBO J. 12, 3474-3485.
42. 42. Ahmad, S., Alsayed, Y.M., Druker, B.J., and Platanias, L.C. (1997). The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272, 29991-29994.
43. 43. Gotoh, T., Hattori, S., Nakmura, S., Kitayama, H., Noda, M., Takai, Y., Kaibuchi, K., Matsui, H., Hatase, O., Takahashi, H., Kurata, T., and Matsuda, M. (1995). Identification of Rap1 as a target for the Crk SH3 domain binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15, 6746-6753.
44. 44. Xu, J., Rockow, S., Kim, S., Xiong, W., and Li, W. (1994). Interferons block protein kinase C-dependent but not -independent activation of Raf-1 and mitogen-activated protein kinases and mitogenesis in NIH 3T3 cells. Mol. Cell. Biol. 14, 8018-8027.
45. 45. Pfeffer, L.M., Strulovici, B., and Saltiel, A.R. (1990). Interferon-α-selectively activates the β isoform of protein kinase C through phosphatidylcholine hydrolysis. Proc. Natl. Acad. Sci. USA 87, 6537-6541.
46. 46. Kessler, D.S., and Levy, D.E. (1991). Protein kinase activity required for an early step in interferon-α signaling. J. Biol. Chem. 266, 23471-23476.
47. 47. Yu, F., and Floyd-Smith, G. (1997). Protein kinase C is required for induction of 2′,5′-oligoadenylate synthetases. Exp. Cell. Res. 234, 240-248.
48. 48. Yamaguchi, K., Ogita, K., Nakamura, S.-I., and Nishizuka, Y. (1995). The protein kinase C isoforms leading to MAP-kinase activation in CHO cells. Biochem. Biophys. Res. Commun. 210, 639-647.
49. 49. Ueda, Y., Hirai, S.-I., Osada, S.-I., Suzuki, A., Mizuno, K., and Ohno, S., (1996). Protein kinase C δ activates the MEKERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271, 23512-23519.
50. 50. Lahooti, H., Thorsen, T., and Aakvaag, A. (1998). Modulation of mouse estrogen receptor transcription activity by protein kinase C δ. J. Mol. Endocrinol. 20, 245-259.
51. 51. Ekena, K., Weis, K.E., Katzenellenbogen, J.A., and Katzenellenbogen, B.S. (1996). Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding. J. Biol. Chem. 271, 20053-20059.
52. 52. Fawell, S.E., Lees, J.A., White, R., and Parker, M.G. (1990). Characterization and colocalization of the steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60, 953-962.
53. 53. ARNOLD, S.F., and NOTIDES, A.C. (1995). An antiestrogen: a phosphotyrosyl peptide that blocks dimerization of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 92, 7475-7479.
54. 54. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.-R., and Chambon, P. (1987). Functional domains of the human estrogen receptor. Cell 51, 941-951.
55. 55. Malayer, J.R. (1996). Bovine estrogen receptor hormone-binding domain, exons V-VII. GenBank Accession no. U64962.
56. 56. Migliaccio, A., Rotondi, A., and Auricchio, F. (1984). Calmodulin-stimulated phosphorylation of 17β-estradiol receptor on tyrosine. Proc. Natl. Acad. Sci. USA 81, 5921-5925.
57. 57. Notides, A.C., Lerner, N., and Hamilton, D.E. (1981). Positive cooperativity of the estrogen receptor. Proc. Natl. Acad. Sci. USA 78, 4926-4930.
58. 58. Castoria, G., Migliaccio, A., Green, S., Didomenico, M., Chambon, P., and Auricchio, F. (1993). Properties of a purified estradiol-dependent calf uterus tyrosine kinase. Biochemistry 32, 1740-1750.
59. 59. White, R., Sjöberg, M., Kalkhoven, E., and Parker, M.G. (1997). Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16, 1427-1435.
60. 60. Arnold, S.F., Obourn, J.D., Jaffe, H., and Notides, A.C. (1995). Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by Src family tyrosine kinases in vitro. Mol. Endocrinol. 9, 24-33.
61. 61. Nel, A.E., Hanekom, C., and Hultin, L. (1991). Protein kinase C plays a role in the induction of tyrosine phosphorylation of lymphoid microtubule-associated protein-2 kinase. J. Immunol. 147, 1933-1939.
62. 62. Guilbaud, N., Pichon, M.F., Faye, J.C., Bayard, F., and Valette, A. (1988). Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line. Mol. Cell. Endocrinol. 56, 157-163.
63. 63. Martin, M.B., Garcia-Morales, P., Stoica, A., Solomon, H.B., Pierce, M., Katz, D., Zhang, S., Danielsen, M., and Saceda, M. (1995). Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J. Biol. Chem. 270, 25244-25251.
64. 64. Saceda, M., Knabbe, C., Dickson, R.B., Lippman, M.E., Bronzert, D., Lindsey, R.K., Gottardis, M.M., and Martin, M.B. (1991). Posttranscriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266, 17809-17814.
65. 65. Tzukerman, M., Zhang, X.-K., and Pfahl, M. (1991). Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol. 5, 1983-1992.